Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.

Hansen J, Sun M, Bianchi M, Rink M, Tian Z, Hanna N, Meskawi M, Schmitges J, Shariat SF, Chun FK, Perrotte P, Graefen M, Karakiewicz PI.

Urology. 2012 Aug;80(2):347-53. doi: 10.1016/j.urology.2012.04.043. Epub 2012 Jun 13.

PMID:
22698478
[PubMed - indexed for MEDLINE]
2.

Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.

Jeldres C, Patard JJ, Capitanio U, Perrotte P, Suardi N, Crepel M, Ficarra V, Cindolo L, de La Taille A, Tostain J, Pfister C, Albouy B, Colombel M, Méjean A, Lang H, Jacqmin D, Bernhard JC, Ferrière JM, Bensalah K, Karakiewicz PI.

Urology. 2009 Jun;73(6):1300-5. doi: 10.1016/j.urology.2008.08.492. Epub 2009 Apr 18.

PMID:
19376568
[PubMed - indexed for MEDLINE]
3.

Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.

Yoo C, Song C, Hong JH, Kim CS, Ahn H.

J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.

PMID:
18550101
[PubMed - indexed for MEDLINE]
4.

The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.

Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.

J Urol. 2002 Jul;168(1):56-60.

PMID:
12050492
[PubMed - indexed for MEDLINE]
5.

Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy.

Breau RH, Crispen PL, Jimenez RE, Lohse CM, Blute ML, Leibovich BC.

J Urol. 2010 Mar;183(3):903-8. doi: 10.1016/j.juro.2009.11.037. Epub 2010 Jan 18.

PMID:
20083271
[PubMed - indexed for MEDLINE]
6.

Laparoscopic radical nephrectomy for large renal masses: critical assessment of perioperative and oncologic outcomes of stage T2a and T2b tumors.

Pierorazio PM, Hyams ES, Lin BM, Mullins JK, Allaf ME.

Urology. 2012 Mar;79(3):570-5. doi: 10.1016/j.urology.2011.10.065.

PMID:
22386399
[PubMed - indexed for MEDLINE]
7.

Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.

Gorin MA, Ball MW, Pierorazio PM, Tanagho YS, Bhayani SB, Kaouk JH, Rogers CG, Stifelman MD, Khalifeh A, Kumar R, Sivarajan G, Allaf ME.

J Urol. 2013 Nov;190(5):1907-11. doi: 10.1016/j.juro.2013.06.014. Epub 2013 Jun 11.

PMID:
23764083
[PubMed - indexed for MEDLINE]
8.

Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.

Simmons MN, Weight CJ, Gill IS.

Urology. 2009 May;73(5):1077-82. doi: 10.1016/j.urology.2008.11.059.

PMID:
19394509
[PubMed - indexed for MEDLINE]
9.

Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.

Sun M, Bianchi M, Hansen J, Abdollah F, Trinh QD, Lughezzani G, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI.

Int J Urol. 2013 Apr;20(4):372-80. doi: 10.1111/j.1442-2042.2012.03170.x. Epub 2012 Oct 8.

PMID:
23039208
[PubMed - indexed for MEDLINE]
10.

Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.

Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.

BJU Int. 2012 May;109(10):1457-62. doi: 10.1111/j.1464-410X.2011.10597.x. Epub 2011 Sep 20.

PMID:
21933334
[PubMed - indexed for MEDLINE]
11.

A non-cancer-related survival benefit is associated with partial nephrectomy.

Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI.

Eur Urol. 2012 Apr;61(4):725-31. doi: 10.1016/j.eururo.2011.11.047. Epub 2011 Dec 3.

PMID:
22172373
[PubMed - indexed for MEDLINE]
12.

Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.

Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI.

Urology. 2010 Feb;75(2):271-5. doi: 10.1016/j.urology.2009.04.098. Epub 2009 Dec 4.

PMID:
19962740
[PubMed - indexed for MEDLINE]
13.

A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.

Crépel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, Capitanio U, Shariat SF, Arjane P, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.

Urology. 2010 Oct;76(4):883-8. doi: 10.1016/j.urology.2009.08.028.

PMID:
20932408
[PubMed - indexed for MEDLINE]
14.

Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?

Jeldres C, Sun M, Liberman D, Lughezzani G, de la Taille A, Tostain J, Valeri A, Cindolo L, Ficarra V, Artibani W, Zigeuner R, Mejean A, Descotes JL, Lechevallier E, Mulders PF, Perrotte P, Patard JJ, Karakiewicz PI.

J Urol. 2009 Dec;182(6):2585-9. doi: 10.1016/j.juro.2009.08.053.

PMID:
19836799
[PubMed - indexed for MEDLINE]
15.

Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy.

Weight CJ, Lythgoe C, Unnikrishnan R, Lane BR, Campbell SC, Fergany AF.

Urology. 2011 May;77(5):1142-6. doi: 10.1016/j.urology.2010.11.058. Epub 2011 Mar 21.

PMID:
21420154
[PubMed - indexed for MEDLINE]
16.

An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.

J Urol. 2002 Dec;168(6):2395-400.

PMID:
12441925
[PubMed - indexed for MEDLINE]
17.

Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patients.

Meskawi M, Sun M, Ismail S, Bianchi M, Hansen J, Tian Z, Hanna N, Trinh QD, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.

Mod Pathol. 2013 Aug;26(8):1144-9. doi: 10.1038/modpathol.2012.230. Epub 2013 Feb 1. Erratum in: Mod Pathol. 2013 Aug;26(8):1152.

PMID:
23370773
[PubMed - indexed for MEDLINE]
Free Article
18.

Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.

Lau WK, Cheville JC, Blute ML, Weaver AL, Zincke H.

Urology. 2002 Apr;59(4):532-7.

PMID:
11927308
[PubMed - indexed for MEDLINE]
19.

Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.

Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H.

J Urol. 1996 Jun;155(6):1868-73.

PMID:
8618276
[PubMed - indexed for MEDLINE]
20.

Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.

Ghavamian R, Cheville JC, Lohse CM, Weaver AL, Zincke H, Blute ML.

J Urol. 2002 Aug;168(2):454-9.

PMID:
12131287
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk